Recently, a new class of aPL, the autoantibodies recognizing the phosphatidylserine/prothrombin complex (aPS/PT), is emerging as a possible additional member of the APS classification criteria [2], due to their elevated correlation with LAC and thrombotic events [3–5]. Here, F2 is linked to autoimmune polyendocrinopathy.